Department of Anaesthesiology, University Hospital RWTH Aachen, Aachen, Germany.
Center for Translational & Clinical Research Aachen (CTC-A), Medical Faculty RWTH Aachen University, Aachen, Germany.
PLoS One. 2022 Jan 4;17(1):e0262110. doi: 10.1371/journal.pone.0262110. eCollection 2022.
The demographic development suggests a dramatic growth in the number of elderly patients undergoing surgery in Europe. Most red blood cell transfusions (RBCT) are administered to older people, but little is known about perioperative transfusion practices in this population. In this secondary analysis of the prospective observational multicentre European Transfusion Practice and Outcome Study (ETPOS), we specifically evaluated intraoperative transfusion practices and the related outcomes of 3149 patients aged 65 years and older. Enrolled patients underwent elective surgery in 123 European hospitals, received at least one RBCT intraoperatively and were followed up for 30 days maximum. The mean haemoglobin value at the beginning of surgery was 108 (21) g/l, 84 (15) g/l before transfusion and 101 (16) g/l at the end of surgery. A median of 2 [1-2] units of RBCT were administered. Mostly, more than one transfusion trigger was present, with physiological triggers being preeminent. We revealed a descriptive association between each intraoperatively administered RBCT and mortality and discharge respectively, within the first 10 postoperative days but not thereafter. In our unadjusted model the hazard ratio (HR) for mortality was 1.11 (95% CI: 1.08-1.15) and the HR for discharge was 0.78 (95% CI: 0.74-0.83). After adjustment for several variables, such as age, preoperative haemoglobin and blood loss, the HR for mortality was 1.10 (95% CI: 1.05-1.15) and HR for discharge was 0.82 (95% CI: 0.78-0.87). Pre-operative anaemia in European elderly surgical patients is undertreated. Various triggers seem to support the decision for RBCT. A closer monitoring of elderly patients receiving intraoperative RBCT for the first 10 postoperative days might be justifiable. Further research on the causal relationship between RBCT and outcomes and on optimal transfusion strategies in the elderly population is warranted. A thorough analysis of different time periods within the first 30 postoperative days is recommended.
人口结构的发展表明,在欧洲接受手术的老年患者数量将大幅增加。大多数红细胞输血(RBCT)用于老年人,但对该人群围手术期输血的做法知之甚少。在欧洲前瞻性观察性多中心输血实践和结果研究(ETPOS)的二次分析中,我们专门评估了 3149 名 65 岁及以上患者的术中输血情况和相关结果。入组患者在 123 家欧洲医院接受择期手术,术中至少接受 1 次 RBCT,并在 30 天内进行了随访。手术开始时血红蛋白平均值为 108(21)g/l,输血前为 84(15)g/l,手术结束时为 101(16)g/l。中位数输注 2[1-2]单位的 RBCT。大多数情况下,存在不止一个输血触发因素,其中生理触发因素占主导地位。我们揭示了在术后前 10 天内,每输注 1 单位 RBCT 与死亡率和出院率之间存在描述性关联,但术后 10 天以上无此关联。在未调整模型中,死亡率的风险比(HR)为 1.11(95%CI:1.08-1.15),出院率的 HR 为 0.78(95%CI:0.74-0.83)。在校正了年龄、术前血红蛋白和失血等多个变量后,死亡率的 HR 为 1.10(95%CI:1.05-1.15),出院率的 HR 为 0.82(95%CI:0.78-0.87)。欧洲老年手术患者术前贫血治疗不足。各种触发因素似乎支持了 RBCT 的决策。对接受术中 RBCT 的老年患者在前 10 天术后期间进行更密切的监测可能是合理的。需要进一步研究 RBCT 与结果之间的因果关系以及老年人群的最佳输血策略。建议对术后 30 天内的不同时间段进行全面分析。